Melissa Mendoza JD U.S. FDA

Melissa Mendoza is the Director of the Office of Compliance and Biologics Quality (OCBQ) in the Center for Biologics Evaluation and Research (CBER) at the United States Food and Drug Administration. OCBQ oversees CBER-regulated products over their entire lifecycle, from pre-market review and inspection to post-market review, surveillance, inspection, outreach, and compliance. Prior to her current role, Ms. Mendoza served as OCBQ’s Deputy Director for six years. Before joining CBER, she worked for eight years in FDA’s Office of the Chief Counsel where she was an Associate Chief Counsel for Enforcement.